期刊文献+

HPLC法测定人血浆中奥氮平浓度 被引量:1

Determination of Olanzapine in Plasma by HPLC with UV Detection
下载PDF
导出
摘要 目的 建立测定人血浆中奥氮平浓度的反相高效液相色谱法.方法 以C18反相柱(150mm×4.6mm, 5μm)为色谱柱,流动相0.03mol·L^-1醋酸铵-甲醇(35:65);流速:0.8 ml·min^-1;柱温:40°C;检测波长: 275nm.以乙酸乙酯与二氯甲烷(80:20)为提取剂.结果 奥氮平320.0, 80.0,10.0μg·L^-1 3种浓度平均回收率分别为102.92%, 97.11%,98.20%,日内、日间差RSD均低于6%(n=5);最低检测浓度为5.0μg·L^-1;线性范围为5.0~320.0μg·L^-1.回归方程为:C=264.03F-1.21,r=0.9996(n=9).结论 本法灵敏、准确、简单、快速,可用于临床血药浓度监测和药动学研究. OBJECTIVE To establish a method for determining the plasma concentration of olanzapine by HPLC . METHODS Olanzapine was extracted with diethyl ether. The residues were analyzed with a reverse phase HPLC system Diamonsil C18 column (150mm ×4.6mm, 5μm) with the mobile phase consisted of 0.03mol·L^-1NH4AC-Methanol (35:65). The detection wavelength was at 275nm. RESULTS The average recoveries of olanzapine were 102.92%, 97.11% and 98.20%, respectively. The within-day and between-day precision of variation was less than 6 %. The calibration curves of olanzapine had good linearity, r= 0. 9996 (n= 9), over the range of 5.0~320. 0μg·L^-1 CONCLUSION The method provides a sensitive, accurate precise and reliable analytical procedure for clinical monitoring of olanzapine in plasma and its pharmacokinetics studies.
出处 《海峡药学》 2006年第3期184-186,共3页 Strait Pharmaceutical Journal
关键词 奥氮平 血药浓度 高效液相色谱法 Olanzapine plasma concentration HPLC
  • 相关文献

参考文献6

  • 1陆国才,袁伯俊.新一代抗精神分裂症药物奥氮平[J].中国新药杂志,1999,8(3):161-164. 被引量:52
  • 2Beasley CM Jr,Tollefson GD,Tran PV.Efficacy of olanzapine:an overview of pivotal clinical trials[J].J Clin Psychiatry 1997,58(10):7.
  • 3Berna M,Shugert R,Mullen J.Determination of olanzapine in human plasms and serun by liquid chromatography/tandem mass spectrometry[J].J Mass Spectrom.1998 Oct;33(10):1003~8.
  • 4舒良,刘平,周沫,王希林,张鸿燕,郭俊花,周方,侯也之.奥氮平治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1999,32(4):223-225. 被引量:97
  • 5Boulton DW,Markowitz JS,Devane CL.A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine[J]..J Chromatogr B Biomed Sci Appl.2001 Aug15;759(2):319~23
  • 6Rao ML,Hiemke C,Grasmader K,Baumann P;Olanzpine:pharmacology,pharmacokinetics and therapeutic drug monitoring[J].Fortschr Neurol Psychiatr.2001 Nov;69(11):510~7.

二级参考文献1

  • 1C. M. Beasley,T. Sanger,W. Satterlee,G. Tollefson,P. Tran,S. Hamilton. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial[J] 1996,Psychopharmacology(1-2):159~167

共引文献137

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部